Obesity is a crescent epidemic in the world, affecting more than half a billion of adults worldwide. Obesity is associated to main cardiovascular risk factors, such as insulin resistance, type 2 diabetes mellitus, high blood pressure and dyslipidemia. The excessive adiposity causes a dysregulation of adipokines secretion by adipose tissue, upregulating the expression of pro-inflammatory adipokines and downregulating the anti-inflammatory ones. This scenario contributes for the appearance of atherosclerosis. Since endothelium dysfunction is considered the earliest known marker of the atherosclerotic process, several methods to assess precociously the manifestations of endothelial dysfunction in microvessels, such as venous occlusion plethysmography, laser Doppler flowmetry and nailfold videocapillaroscopy, have been developed. Clinical and experimental studies have shown an impairment of microvascular function, capillary rarefaction and increase in inflammatory status in obesity and the introduction of lifestyle modifications, mainly physical activity and diet, constitute effective interventions to restore microvascular function in obesity.
AbularrageC.J., SidawyA.N., AidinianG., SinghN., WeiswasserJ.M. and AroraS., Evaluation of the microcirculation in vascular disease, J Vasc Surg42 (2005), 574–581.
2.
BaronA.D. and ClarkM.G., Role of blood flow in the regulation of muscle glucose uptake, Annu Rev Nutr17 (1997), 487–499.
3.
BaysH., Adiposopathy, “sick fat,” Ockham’s razor, and resolution of the obesity paradox, Curr Atheroscler Rep16(5) (2014), 409.
4.
BaysH.E., Adiposopathy is “sick fat” a cardiovascular disease, J Am Coll Cardiol57(25) (2011), 2461–2473.
5.
BergA.H. and SchererP.E., Adipose tissue, inflammation, and cardiovascular disease, Circ Res96(9) (2005), 939–949.
6.
BlüherM., Adipokines - removing road blocks to obesity and diabetes therapy, Mol Metab3(3) (2014), 230–240.
7.
BoaB.C., SouzaM.D., LeiteR.D., da SilvaS.V., Barja-FidalgoT.C., Kraemer-AguiarL.G., et al., Chronic aerobic exercise associated to dietary modification improve endothelial function and eNOS expression in high fat fed hamsters, PLoS One9(7) (2014), e102554.
8.
BornsteinS.R., Ehrhart-BornsteinM., WongM.L. and LicinioJ., Is the worldwide epidemic of obesity a communicable feature of globalization?Exp Clin Endocrinol Diabetes116(supppl1) (2008), S30–S32.
9.
CampiaU., TesauroM. and CardilloC., Human obesity and endothelium-dependent responsiveness, Br J Pharmacol165(3) (2012), 561–573.
10.
ChowienczykP.J., WattsG.F., CockcroftJ.R. and RitterJ.M., Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia, Lancet340(8833) (1992), 1430–1432.
11.
CinesD.B., PollakE.S., BuckC.A., LoscalzoJ., ZimmermanG.A., McEverR.P., et al., Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood91(10) (1998), 3527–3561.
12.
ClerkL.H., VincentM.A., JahnL.A., LiuZ., LindnerJ.R. and BarrettE.J., Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle, Diabetes55(5) (2006), 1436–1442.
13.
CostaR.R., VillelaN.R., SouzaM.D., BoaB.C., CyrinoF.Z., SilvaS.V., et al., High fat diet induces central obesity, insulin resistance and microvascular dysfunction in hamsters, Microvasc Res82(3) (2011), 416–422.
14.
CracowskiJ.L., MinsonC.T., Salvat-MelisM. and HalliwillJ.R., Methodological issues in the assessment of skin microvascular endothelial function in humans, Trends Pharmacol Sci27(9) (2006), 503–508.
15.
CrimiE., IgnarroL.J. and NapoliC., Microcirculation and oxidative stress, Free Radic Res41(12) (2007), 1364–1375.
16.
de GraafJ.C., BangaJ.D., MoncadaS., PalmerR.M., de GrootP.G. and SixmaJ.J., Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions, Circulation85(6) (1992), 2284–2290.
17.
de JonghR.T., SernéE.H., IJzermanR.G., de VriesG. and StehouwerC.D.A., Impaired Microvascular Function in Obesity Implications for Obesity-Associated Microangiopathy, Hypertension, and Insulin Resistance, Circulation109 (2004), 2529–2535.
18.
DeanfieldJ.E., HalcoxJ.P. and RabelinkT.J., Endothelial function and dysfunction: Testing and clinical relevance, Circulation115 (2007), 1285–1295.
19.
den UilC.A., KlijnE., LagrandW.K., BrugtsJ.J., InceC., SpronkP.E., et al., The microcirculation in health and critical disease, Prog Cardiovasc Dis51(2) (2008), 161–170.
20.
DulingB.R., The preparation and use of the hamster cheek pouch for studies of the microcirculation, Microvasc Res5(3) (1973), 423–429.
21.
EndrichB., AsaishiK., GötzA. and MessmerK., Technical report— a new chamber technique for microvascular studies in unanesthetized hamsters, Res Exp Med (Berl)177(2) (1980), 125–134.
22.
EringaE.C., BakkerW., SmuldersY.M., SernéE.H., YudkinJ.S. and StehouwerC.D., Regulation of vascular function and insulin sensitivity by adipose tissue: Focus on perivascular adipose tissue, Microcirculation14(4-5) (2007), 389–402.
23.
EsmonC., The protein C pathway, Crit Care Med28(9 Suppl) (2000), S44–S48.
24.
FagrellB. and IntagliettaM., Microcirculation: Its significance in clinical and molecular medicine, J Intern Med241(5) (1997), 349–362.
25.
FaloiaE., GattiC., CamilloniM.A., MarinielloB., SarduC., GarrapaG.G., et al., Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects, J Endocrinol Invest25(4) (2002), 309–314.
26.
Freitas LimaL.C., BragaV.A., do Socorro de França SilvaM., CruzJ.C., Sousa SantosS.H., de Oliveira MonteiroM.M., et al., Adipokines, diabetes and atherosclerosis: An inflammatory association, Front Physiol6 (2015), 304.
27.
FrisbeeJ.C., SamoraJ.B., PetersonJ. and BrynerR., Exercise training blunts microvascular rarefaction in the metabolic syndrome, Am J Physiol Heart Circ Physiol291 (2006), H2483–H2492.
28.
GabouryJ.P., AndersonD.C. and KubesP., Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo, Am J Physiol266(2 Pt 2) (1994), H637–H642.
29.
GabouryJ., WoodmanR.C., GrangerD.N., ReinhardtP. and KubesP., Nitric oxide prevents leukocyte adherence: Role of superoxide, Am J Physiol265(3 Pt 2) (1993), H862–H867.
30.
GhiadoniL., FaitaF., SalvettiM., CordianoC., BiggiA., PuatoM., et al., Assessment of flow-mediated dilation reproducibility: A nationwide multicenter study, J Hypertens30(7) (2012), 1399–1405.
31.
GillJ.M., Al-MamariA., FerrellW.R., ClelandS.J., PackardC.J., SattarN., et al., Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men, J Am Coll Cardiol44(12) (2004), 2375–2382.
32.
GrangerD.N. and KubesP., The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion, J Leukoc Biol55 (1994), 662–675.
33.
GuttermanD.D., ChabowskiD.S., KadlecA.O., DurandM.J., FreedJ.K., Ait-AissaK., et al., The human microcirculation: Regulation of flow and beyond, Circ Res118(1) (2016), 157–172.
34.
GyawaliP., RichardsR.S., HughesD.L. and TinleyP., Erythrocyte aggregation and metabolic syndrome, Clin Hemorheol Microcirc57(1) (2014), 73–83.
35.
HolowatzL.A., Thompson-TorgersonC.S. and KenneyW.L., The human cutaneous circulation as a model of generalized microvascular function, J Appl Physiol (1985)105(1) (2008), 370–372.
36.
JensenL., PilegaardH., NeuferP.D. and HellstenY., Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle, Am J Physiol Regul Integr Comp Physiol287(2) (2004), R397–R402.
37.
JoynerM.J., DietzN.M. and ShepherdJ.T., From Belfast to Mayo and beyond: The use and future of plethysmography to study blood flow in human limbs, J Appl Physiol91(6) (2001), 2431–2441.
38.
KlijnE., Den UilC.A., BakkerJ. and InceC., The heterogeneity of the microcirculation in critical illness, Clin Chest Med29(4) (2008), 643–654.
39.
Kraemer-AguiarL.G., LaflorC.M. and BouskelaE., Skin microcirculatory dysfunction is already present in normoglycemic subjects with metabolic syndrome, Metabolism57(12) (2008), 1740–1746.
40.
Kraemer-AguiarL.G., MaranhãoP.A., CyrinoF.Z. and BouskelaE., Waist circumference leads to prolonged microvascular reactive hyperemia response in young overweight/obese women, Microvasc Res80(3) (2010), 427–432.
41.
KubesP., KanwarS., NiuX.F. and GabouryJ.P., Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells, FASEB J7 (1993), 1293–1299.
42.
KubesP., SuzukiM. and GrangerD.N., Nitric oxide: An endogenous modulator of leukocyte adhesion, Proc Natl Acad Sci USA88 (1991), 4651–4655.
43.
KuroseI., KubesP., WolfR., AndersonD.C., PaulsonJ., MiyasakaM., et al., Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage, Circ Res73 (1993), 164–171.
44.
LekakisJ., AbrahamP., BalbariniA., BlannA., BoulangerC.M., CockcroftJ., et al., Methods for evaluating endothelial function: A position statement from the European Society of Cardiology Working Group on Peripheral Circulation, Eur J Cardiovasc Prev Rehabil18(6) (2011), 775–789.
45.
LimS.S., VosT., FlaxmanA.D., DanaeiG., ShibuyaK., Adair-RohaniH., et al., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, – : A systematic analysis for the Global Burden of Disease Study, Lancet380(9859) (2012), 2224–2260.
46.
MaranhãoP.A., de SouzaM.D., Kraemer-AguiarL.G. and BouskelaE., Dynamic nailfold videocapillaroscopy may be used for early detection of microvascular dysfunction in obesity, Microvasc Res106 (2016), 31–35.
MontaniJ.P., AnticV., YangZ. and DullooA., Pathways from obesity to hypertension: From the perspective of a vicious triangle, Int J Obes Relat Metab Disord26(Suppl 2) (2002), S28–S38.
49.
MonteroD., WaltherG., Perez-MartinA., SantamariaC., RocheE., MercierC., et al., Decreased microvascular myogenic response to insulin in severely obese adolescents, Clin Hemorheol Microcirc57(1) (2014), 23–32.
50.
OuchiN., KiharaS., FunahashiT., MatsuzawaY. and WalshK., Obesity, adiponectin and vascular inflammatory disease, Curr Opin Lipidol14(6) (2003), 561–566.
51.
OuchiN., ParkerJ.L., LugusJ.J. and WalshK., Adipokines in inflammation and metabolic disease, Nat Rev Immunol11(2) (2011), 85–97.
52.
PanzaJ.A., QuyyumiA.A. and BrushJ.E.Jr and EpsteinS.E., Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension, N Engl J Med323(1) (1990), 22–27.
53.
PearsonJ.D., Endothelial cell function and thrombosis, Baillieres Best Pract Res Clin Haematol12(3) (1999), 329–324.
54.
PoberJ.S. and SessaW.C., Evolving functions of endothelial cells in inflammation, Nat Rev Immunol7(10) (2007), 803–815.
55.
RubanyiG.M., The role of endothelium in cardiovascular homeostasis and diseases, J Cardiovasc Pharmacol22(Suppl 4) (1993), S1–14.
56.
SadlerJ.E., Thrombomodulin structure and function, Thromb Haemost78(1) (1997), 392–395.
57.
SaxF.L., CannonR.O., HansonC. and EpsteinS.E., Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function, N Engl J Med317 (1987), 1366–1370.
58.
SidelmannJ.J., GramJ., JespersenJ. and KluftC., Fibrin clot formation and lysis: Basic mechanisms, Semin Thromb Hemost26(6) (2000), 605–618.
59.
SingerG. and GrangerD.N., Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance, Microcirculation14(4-5) (2007), 375–387.
60.
SourijH., ZweikerR. and WascherT.C., Effects of Pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and New-Onset Type 2, Diabetes Diabetes Care29(5) (2006), 1039–1045.
61.
SternD.M., EspositoC., GerlachH., GerlachM., RyanJ., HandleyD. and NawrothP., Endothelium and regulation of coagulation, Diabetes Care14(2) (1991), 160–166.
62.
SuzukiM., GrishamM.B. and GrangerD.N., Leukocyte-endothelial cell adhesive interactions: Role of xanthine oxidase-derived oxidants, J Leukoc Bio50 (1991), 488–494.
63.
TaddeiS., GhiadoniL., VirdisA., VersariD. and SalvettiA., Mechanisms of endothelial dysfunction: Clinical significance and preventive non-pharmacological therapeutic strategies, Curr Pharm Des9 (2003), 2385–2402.
64.
TodaN. and OkamuraT., Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: An overview, J Clin Pharmacol53(12) (2013), 1228–1239.
65.
TreuC.M., LupiO., BottinoD.A. and BouskelaE., Sidestream dark field imaging: The evolution of real-time visualization of cutaneous microcirculation and its potential application in dermatology, Arch Dermatol Res303(2) (2011), 69–78.
66.
TurnerJ., BelchJ.J. and KhanF., Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis, Trends Cardiovasc Med18(4) (2008), 109–116.
67.
Van de VoordeJ., PauwelsB., BoydensC. and DecaluwéK., Adipocytokines in relation to cardiovascular disease, Metabolism62(11) (2013), 1513–1521.
68.
Van GaalL.F., MertensI.L. and De BlockC.E., Mechanisms linking obesity with cardiovascular disease, Nature444(7121) (2006), 875–880.
69.
VanhoutteP.M., Endothelial control of vasomotor function: From health to coronary disease, Circ J67(7) (2003), 572–575.
70.
VayáA., SarnagoA., SuescunM., CamaraR. and LaizB., Rheological red blood cell properties in morbidly obese and super obese patients, Clin Hemorheol Microcirc58(2) (2014), 377–379.
71.
VersariD., DaghiniE., VirdisA., GhiadoniL. and TaddeiS., Endothelial dysfunction as a target for prevention of cardiovascular disease, Diabetes Care32(Suppl 2) (2009), S314–S321.
72.
WheatleyC.M., RattiganS., RichardsS.M., BarrettE.J. and ClarkM.G., Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats, Am J Physiol Endocrinol Metab287(4) (2004), E804–E809.
73.
World Health Organization, Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
74.
ZengG., NystromF.H., RavichandranL.V., CongL.N., KirbyM., MostowskiH., et al., Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells, Circulation101(13) (2000), 1539–1545.
